ORGO vs TROW · rev $81.0M vs P/E 12, rev $3.76B
Organogenesis Holdings Inc (ORGO) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
ORGO currently screens at market cap $301.1M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the ORGO and TROW stock pages for the full models.
Not investment advice.